{"id":"W2953630757","doi":"10.1016/j.jsxm.2019.05.012","title":"Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide","year":2019,"lang":"en","type":"article","venue":"The Journal of Sexual Medicine","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Biotech; Sage Therapeutics; Alkermes; Covis Pharma; Ministerul Cercetării, Inovării şi Digitalizării; Valeant Pharmaceuticals International","keywords":"Hypoactive sexual desire disorder; Dose-ranging study; Female sexual dysfunction; Medicine; Receiver operating characteristic; Orgasm; Sexual function; Minimal clinically important difference; Sexual desire; Distress; Sexual dysfunction; Internal medicine; Psychology; Clinical psychology; Randomized controlled trial; Placebo; Human sexuality; Double blind; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001146346,0.0001744261,0.0008187167,0.000386011,0.00007264838,0.000004112877,0.0001414607,0.00004292755,0.001627501],"category_scores_gemma":[0.0005490943,0.00008597334,0.00003268738,0.0005054402,0.000119189,0.00009195192,0.00004289048,0.0003751445,0.00003585715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004140699,"about_ca_system_score_gemma":0.00006931109,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004506829,"about_ca_topic_score_gemma":0.00001819997,"domain_scores_codex":[0.9976789,0.000214705,0.0008759031,0.0001366557,0.0009289068,0.0001649709],"domain_scores_gemma":[0.9975317,0.0008726142,0.000597484,0.0003700179,0.0004984346,0.000129809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"qualitative","study_design_scores_codex":[0.02002954,0.001956234,0.02758189,0.00007581947,0.002575184,0.0001189061,0.02283911,0.0001846364,0.90196,0.00001187399,0.0161715,0.006495271],"study_design_scores_gemma":[0.09850118,0.1379409,0.2291296,0.0009173396,0.009098832,0.001003492,0.5012641,0.0003331062,0.006844644,0.0001358772,0.01441445,0.0004164663],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934125,0.001644582,0.0004863256,0.001908586,0.001151828,0.0003181298,0.000003034685,0.00001660731,0.00105841],"genre_scores_gemma":[0.9951271,0.00006213796,0.00005807984,0.00104143,0.000923547,0.000001077091,0.000003727519,0.00001762952,0.002765217],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8951154,"threshold_uncertainty_score":0.9992852,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1570862730073383,"score_gpt":0.4381977896091684,"score_spread":0.2811115166018301,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}